Articles published by Amylyx Pharmaceuticals, Inc.





Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2023
Via Business Wire
Tickers
AMLX

Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer
November 28, 2023
Via Business Wire
Tickers
AMLX

RELYVRIO® and AMX0114 Data to be Presented at 34th International Symposium on ALS/MND
November 27, 2023
Via Business Wire
Tickers
AMLX

Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
Via Business Wire
Tickers
AMLX

Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
Via Business Wire
Tickers
AMLX

Amylyx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 9, 2023
November 02, 2023
Via Business Wire
Tickers
AMLX




RELYVRIO® and AMX0114 Data to be Presented at 22nd Annual Northeast ALS Consortium (NEALS) Meeting
October 02, 2023
Via Business Wire
Tickers
AMLX

Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
September 05, 2023
Via Business Wire
Tickers
AMLX

Via Business Wire
Tickers
AMLX

Amylyx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 10, 2023
August 03, 2023
Via Business Wire
Tickers
AMLX






Via Business Wire
Tickers
AMLX

Via Business Wire
Tickers
AMLX



Amylyx Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
Via Business Wire
Tickers
AMLX

Via Business Wire
Tickers
AMLX

Via Business Wire
Tickers
AMLX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.